Pacer Advisors, Inc. Nektar Therapeutics Transaction History

Pacer Advisors, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$10.83 - $18.41 $310,701 - $528,164	-28,689 Closed	0 $0
Q3 2021 Oct 15, 2021	BUY	$13.07 - $18.84 $124,047 - $178,810	9,491 Added 49.44%	28,689 $515,000
Q2 2021 Jul 21, 2021	SELL	$16.52 - $20.4 $3,816 - $4,712	-231 Reduced 1.19%	19,198 $329,000
Q1 2021 Apr 05, 2021	SELL	$16.56 - $25.46 $7,865 - $12,093	-475 Reduced 2.39%	19,429 $389,000
Q4 2020 Jan 20, 2021	SELL	$15.77 - $19.03 $365,469 - $441,020	-23,175 Reduced 53.8%	19,904 $338,000
Q3 2020 Oct 19, 2020	BUY	$16.59 - $24.79 $714,680 - $1.07 Million	43,079 New	43,079 $715,000
Q1 2020 Apr 23, 2020	SELL	$14.47 - $27.96 $864,394 - $1.67 Million	-59,737 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$15.87 - $23.12 $435,933 - $635,083	27,469 Added 85.13%	59,737 $1.29 Million
Q3 2019 Oct 10, 2019	BUY	$16.91 - $36.27 $171,822 - $368,539	10,161 Added 45.96%	32,268 $588,000
Q2 2019 Aug 12, 2019	BUY	$31.0 - $36.3 $205,003 - $240,051	6,613 Added 42.68%	22,107 $787,000
Q1 2019 Apr 10, 2019	SELL	$31.58 - $46.35 $359,917 - $528,250	-11,397 Reduced 42.38%	15,494 $521,000
Q4 2018 Feb 13, 2019	BUY	$30.43 - $56.65 $107,691 - $200,484	3,539 Added 15.16%	26,891 $884,000
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $741,455 - $1.09 Million	15,959 Added 215.87%	23,352 $1.42 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $57,350 - $129,518	1,240 Added 20.15%	7,393 $361,000
Q1 2018 May 14, 2018	BUY	$57.4 - $108.44 $353,182 - $667,231	6,153 New	6,153 $654,000

146

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $214M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.